Cargando…

Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury

Rifampicin is a first-line antituberculosis drug. Hepatocyte toxicity caused by rifampicin is a significant clinical problem. However, the specific mechanism by which rifampicin causes liver injury is still poorly understood. Endoplasmic reticulum (ER) stress can have both protective and proapoptoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Wanqing, Nsengimana, Bernard, Yan, Chuyun, Nashan, Bjorn, Han, Shuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630567/
https://www.ncbi.nlm.nih.gov/pubmed/36339603
http://dx.doi.org/10.3389/fphar.2022.1022809
_version_ 1784823630824210432
author Hou, Wanqing
Nsengimana, Bernard
Yan, Chuyun
Nashan, Bjorn
Han, Shuxin
author_facet Hou, Wanqing
Nsengimana, Bernard
Yan, Chuyun
Nashan, Bjorn
Han, Shuxin
author_sort Hou, Wanqing
collection PubMed
description Rifampicin is a first-line antituberculosis drug. Hepatocyte toxicity caused by rifampicin is a significant clinical problem. However, the specific mechanism by which rifampicin causes liver injury is still poorly understood. Endoplasmic reticulum (ER) stress can have both protective and proapoptotic effects on an organism, depending on the environmental state of the organism. While causing cholestasis and oxidative stress in the liver, rifampicin also activates ER stress in different ways, including bile acid accumulation and cytochrome p450 (CYP) enzyme-induced toxic drug metabolites via pregnane X receptor (PXR). The short-term stress response helps the organism resist toxicity, but when persisting, the response aggravates liver damage. Therefore, ER stress may be closely related to the “adaptive” mechanism and the apoptotic toxicity of rifampicin. This article reviews the functional characteristics of ER stress and its potentially pathogenic role in liver injury caused by rifampicin.
format Online
Article
Text
id pubmed-9630567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96305672022-11-04 Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury Hou, Wanqing Nsengimana, Bernard Yan, Chuyun Nashan, Bjorn Han, Shuxin Front Pharmacol Pharmacology Rifampicin is a first-line antituberculosis drug. Hepatocyte toxicity caused by rifampicin is a significant clinical problem. However, the specific mechanism by which rifampicin causes liver injury is still poorly understood. Endoplasmic reticulum (ER) stress can have both protective and proapoptotic effects on an organism, depending on the environmental state of the organism. While causing cholestasis and oxidative stress in the liver, rifampicin also activates ER stress in different ways, including bile acid accumulation and cytochrome p450 (CYP) enzyme-induced toxic drug metabolites via pregnane X receptor (PXR). The short-term stress response helps the organism resist toxicity, but when persisting, the response aggravates liver damage. Therefore, ER stress may be closely related to the “adaptive” mechanism and the apoptotic toxicity of rifampicin. This article reviews the functional characteristics of ER stress and its potentially pathogenic role in liver injury caused by rifampicin. Frontiers Media S.A. 2022-10-20 /pmc/articles/PMC9630567/ /pubmed/36339603 http://dx.doi.org/10.3389/fphar.2022.1022809 Text en Copyright © 2022 Hou, Nsengimana, Yan, Nashan and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Hou, Wanqing
Nsengimana, Bernard
Yan, Chuyun
Nashan, Bjorn
Han, Shuxin
Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
title Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
title_full Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
title_fullStr Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
title_full_unstemmed Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
title_short Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
title_sort involvement of endoplasmic reticulum stress in rifampicin-induced liver injury
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630567/
https://www.ncbi.nlm.nih.gov/pubmed/36339603
http://dx.doi.org/10.3389/fphar.2022.1022809
work_keys_str_mv AT houwanqing involvementofendoplasmicreticulumstressinrifampicininducedliverinjury
AT nsengimanabernard involvementofendoplasmicreticulumstressinrifampicininducedliverinjury
AT yanchuyun involvementofendoplasmicreticulumstressinrifampicininducedliverinjury
AT nashanbjorn involvementofendoplasmicreticulumstressinrifampicininducedliverinjury
AT hanshuxin involvementofendoplasmicreticulumstressinrifampicininducedliverinjury